Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.210
-0.030 (-2.42%)
At close: Nov 22, 2024, 4:00 PM
1.200
-0.010 (-0.83%)
After-hours: Nov 22, 2024, 6:23 PM EST

Century Therapeutics Revenue

Century Therapeutics had revenue of $791.00K in the quarter ending September 30, 2024, with 434.46% growth. This brings the company's revenue in the last twelve months to $2.68M, up 7.88% year-over-year. In the year 2023, Century Therapeutics had annual revenue of $2.24M, down -57.01%.

Revenue (ttm)
$2.68M
Revenue Growth
+7.88%
P/S Ratio
32.59
Revenue / Employee
$16,267
Employees
165
Market Cap
102.89M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.24M-2.96M-57.01%
Dec 31, 20225.20M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Quipt Home Medical 244.23M
FONAR 102.01M
Akoya Biosciences 86.82M
Journey Medical 57.77M
Avalo Therapeutics 820.00K
Adagene 815.75K
Inovio Pharmaceuticals 203.41K
INmune Bio 42.00K
Revenue Rankings